Breaks Categories: Stock Spotlights

FridayJul 28, 2017 12:12 pm

CannabisNewsBreaks – Algae Dynamics Corp. (ADYNF) Developing Potential Breakthrough Fortified Formulas to Boost Human Endocannabinoid System

As debates continue over the legalization of marijuana, many individuals who have never touched plant-derived cannabinoids (phytocannabinoids) do not realize that their bodies naturally produce endocannabinoids, which play an essential mediating role in various human physiologic systems. Recent studies have shown that the production of endocannabinoids is boosted by fatty acids, and Algae Dynamics (OTCQB: ADYNF) has begun developing fortified formulas of omega-3s and cannabis oil that could potentially boost the function of the human body’s endocannabinoid system. “The products under development by Algae Dynamics promise to pack a powerful therapeutic punch, combining the virtues of omega-3s and cannabinoids. Algae…

Continue Reading

FridayJul 28, 2017 12:09 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (LXRP) Well-Positioned for Growth as First Mover in Canada’s Cannabinoid Market

Among players in Canada’s emerging cannabinoid market, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is well-positioned for growth. Lexaria is a revenue-generating company engaged in developing and out-licensing proprietary technology for delivering bioactive compounds, including cannabinoids, and the company’s products utilize this patented lipophilic technology, which has been proven to enhance the bioavailability of orally ingested cannabinoids and also improve their taste. “With full legalization expected in 2018, the Canadian market for cannabis extracts and oils is expected to top C$1.6 billion by 2020. Lexaria is at the forefront of innovation in the biosciences sector as pioneering biopharmaceutical companies in…

Continue Reading

MondayJul 17, 2017 2:55 pm

CannabisNewsBreaks – Algae Dynamics Corp. (ADYNF) is Revolutionizing Plant-Based Therapeutics for a Range of Ailments

Algae Dynamics Corp. (OTC: ADYNF) has developed a unique strategy of producing a variety of products that combine the health benefits of both algae and cannabis oils. The synergistic effects of the two plant-based remedies hold tremendous promise, and the ability to sell and cross market the products to health conscious consumers gives the company real competitive advantages. A recent CNW article highlights the company’s progress in this innovative endeavor and notes key partnerships established to achieve its corporate goals: “With an ongoing commitment to science, Algae Dynamics has engaged two Canadian universities to perform research and product development into…

Continue Reading

MondayJul 17, 2017 2:10 pm

CannabisNewsBreaks – SinglePoint (SING) Serves Legal Cannabis Market with Bitcoin Payment Solution; Invests in Equipment, Consulting Space

SinglePoint, Inc. (OTC: SING) is serving up prime opportunities for investors as it expands its array of offerings for the legal cannabis market—all without ever touching the marijuana plant. Many savvy investors are jumping aboard the cannabis bandwagon, and SinglePoint is involved in two of the most promising investment options currently available in that market: bitcoin digital currency as a solution for currently “unbankable” marijuana businesses and hydroponics products and consulting for marijuana growers. “More and more investment opportunities are arising in the legal cannabis industry, and SinglePoint is poised to be a major player. Through its subsidiary, SingleSeed (www.SingleSeed.com),…

Continue Reading

ThursdayJun 29, 2017 12:22 pm

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (IMLFF) Poised to Benefit from Scientific Reviews Concerning Medical Efficacy of Cannabinoids

An increasing volume of research demonstrates the medical efficacy of cannabinoids to treat a variety of medical concerns. InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems, currently has two potential blockbuster therapies in development that are undergoing scientific review. “With areas of research in dermatology, ocular indications, pain and inflammation, central nervous system disorders, and respiratory and metabolic diseases, InMed’s current pipeline is targeting unmet medical conditions utilizing disease-specific formulations. InMed’s INM-750 may become the first therapy to modulate disease activity…

Continue Reading

WednesdayJun 28, 2017 12:12 pm

CannabisNewsBreaks – Algae Dynamics Corp. (ADYNF) Targets Nutraceutical Market Leveraging Health and Efficacy Effects of Algae-Cannabis Oils

The nutraceutical industry boasts a diversified playing field, and Canada-based Algae Dynamics Corp. (OTCQB: ADYNF) is taking a unique approach to this burgeoning market, focusing on the development of proprietary research and products that combine the health benefits of botanical oils derived from cannabis and algae. “The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed…

Continue Reading

ThursdayJun 22, 2017 1:45 pm

CannabisNewsBreaks – Positive Media Attention Recognizes InMed Pharmaceuticals’ (IMLFF) Operational Developments, Leadership Team

Ongoing media coverage continues to recognize and highlight the achievements of InMed Pharmaceuticals, Inc. (OTCQB: IMLFF), a preclinical biopharmaceutical company focused on developing therapies through research and development into the pharmacology of cannabinoids and drug delivery systems. The company was featured as a “Cannabis Runner” by Insider Financial earlier this year, and Forbes also more recently released an article calling InMed “more than just another cannabis drug company.” “Although the company’s pipeline is expected to generate a significant amount of attention in 2018, InMed Pharmaceuticals’ manufacturing system and database are catching the eye of investors and biotech companies. THC and…

Continue Reading

ThursdayJun 15, 2017 12:15 pm

CannabisNewsBreaks – SinglePoint’s (SING) Bitcoin Solution Could Make Marijuana Industry’s Banking Problems a Thing of the Past

Marijuana has now been legalized in some form in 29 states and in the District of Columbia, yet marijuana dispensaries and other cannabis-related businesses lack access to banking options, forcing them to conduct cash only transactions. SinglePoint, Inc. (OTC: SING) may at last have found the answer for these currently “unbankable” businesses by developing a bitcoin payment solution that would enable cannabis users to purchase marijuana products using debit or credit cards. “The company’s SingleSeed subsidiary is already engaged in offering mobile marketing and payment solutions to businesses in the marijuana industry, including cashless ATM, Pay-by-Text™ and text message marketing.…

Continue Reading

WednesdayJun 14, 2017 10:55 am

CannabisNewsBreaks – Research Report Highlights Hefty Market Potential for ChineseInvestors.com, Inc. (CIIX)

ChineseInvestors.com, Inc. (OTCQB: CIIX), which recently took part in SeeThruEquity’s 6th Annual Microcap Investor Conference in early June, offers educational consulting services for Chinese investors and is also pursuing opportunities in the cannabis market.  SeeThruEquity recently increased the price target on CIIX to $3.75 from $2.05, and predicted that revenues from the company’s hemp business could reach 8-digit sales by 2020. “The goal of the company is to be a leading publicly-traded company within the nutritional industry. In addition to its online store based in the free trade zone of Shanghai, China, CIIX is building its first retail store in…

Continue Reading

WednesdayJun 07, 2017 3:13 pm

CannabisNewsBreaks – Player’s Network (PNTV) Shares Continue Two-Day Streak, Set Second New High this Week

Shares of Player’s Network (OTCQB: PNTV) are up 7% at $0.10 near market close, moving on volume of 5.83 million and setting a new 52-week high for the third time since last Friday. On June 2, PNTV announced (http://nnw.fm/2s34T) that its majority owned Green Leaf Farms subsidiary had completed the first phase of construction for its marijuana cultivation and production facility in North Las Vegas. This achievement was preceded by news earlier in the week that Green Leaf received two Nevada state-issued recreational marijuana licenses, as well as medical marijuana licenses (http://nnw.fm/9XLst). PNTV said the licenses create another revenue stream…

Continue Reading